MINOCIN SA Modified release hard capsule Ref.[50816] Active ingredients: Minocycline

Dosage

Adults: One 100mg capsule every 24 hours.

Children over 12 years: One 100mg capsule every 24 hours.

Children under 12 years: Minocin is not recommended.

Elderly: No special dosing requirements.

Administration

To reduce the risk of oesophageal irritation and ulceration, the capsules should be swallowed whole with plenty of fluid, while sitting or standing. Unlike earlier tetracyclines, absorption of minocycline is not significantly impaired by food or moderate amounts of milk.

Treatment of acne should be continued for a minimum of 6 weeks and where possible limited to a maximum of six months. If, after six months, there is no satisfactory response Minocin SA should be discontinued and other therapies considered. If Minocin SA is to be continued for longer than six months, patients should be monitored (including laboratory investigations) at least three monthly thereafter for signs and symptoms of hepatitis or systemic lupus erythematosus (SLE) or unusual pigmentation (see Special warnings and precautions for use).

Dizziness, nausea and vomiting are the adverse effects most commonly seen with overdose. There is no specific antidote. In cases of overdose, discontinue medication, treat symptomatically with supportive measures. Minocin is not removed in significant quantities by haemodialysis or peritoneal dialysis.

24 months.

Do not store above 25°C. Store in the original package.

PVC/PVDC aluminium blister packs containing 2, 7, 28, 49 and 56 capsules.
Polypropylene bottle with urea cap containing 100
capsules.

Not all pack sizes may be marketed.

No special requirements.